Financial Gravity Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-221
Closed -$9.98K 786
2025
Q3
$9.98K Buy
+221
New +$10.3K ﹤0.01% 573
2024
Q2
$706 Sell
17
-23
-58% -$1.03K ﹤0.01% 867
2024
Q1
$2.12K Sell
40
-13
-25% -$662 ﹤0.01% 672
2023
Q4
$2.6K Buy
+53
New +$2.78K ﹤0.01% 683
2021
Q3
$59K Hold
145
0.03% 497
2021
Q2
$67K Buy
+145
New +$9.46K 0.02% 473
2020
Q4
$10K Buy
+161
New +$9.9K 0.01% 174
2019
Q4
$75K Buy
1,626
+976
+150% +$55.9K 0.05% 445
2019
Q3
$33K Buy
650
+327
+101% +$15.4K 0.03% 358
2019
Q2
$15K Sell
323
-222
-41% -$10.3K 0.01% 513
2019
Q1
$26K Buy
+545
New +$27.1K 0.02% 398
2018
Q3
$53K Sell
1,066
-127
-11% -$7.54K 0.06% 302
2018
Q2
$71K Buy
1,193
+256
+27% +$13.8K 0.07% 258
2018
Q1
$48K Buy
+937
New +$60.3K 0.05% 316

Other funds holding BMY

Financial Gravity Asset Management's BMY Position: Q4 2025 in Review

Financial Gravity Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 221 shares — an estimated $9.98K sold.

Financial Gravity Asset Management first reported a position in BMY in Q1 2018 and held it in 14 quarters. The position peaked at $75K in Q4 2019. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Financial Gravity Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
  • Financial Gravity Asset Management sold 221 Bristol-Myers Squibb shares in Q4 2025, an estimated $9.98K.
  • Financial Gravity Asset Management first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 14 quarters.
  • Financial Gravity Asset Management's Bristol-Myers Squibb position peaked at $75K in Q4 2019.
  • 2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Financial Gravity Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.